DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Global Acne Treatment Market: (2017-2021 Edition)" report to their offering.
The global acne treatment market is growing rapidly over the years and is expected to increase further in the forecasted period (2017-2021). Global acne treatment is supported by a number of growth drivers such as rising disposable income, high global prevalence rate of acne, unhealthy eating habits and increasing awareness in teenagers regarding acne treatment etc. Yet, there are certain challenges such as entry of generic drugs, safety issue regarding products and increasing acceptance of ant-acne treatment etc. that hinder the growth of the market.
There are some latest trends that will help the market to grow in the forecasted period. Such trends are laser treatment, shift towards combination products, technology-driven products and efficacy concern on current drugs.
The global acne treatment market is highly fragmented with a large number of niche players. Company profiling of Foamix Pharmaceuticals Ltd., Valeant Pharmaceuticals, Dermira and Allergan (Actavis Plc) has provided in the report. Company profiling is based on attributes like business overview, financial overview and strategies adopted by these companies in order to grow in the market.
- Allergan (Actavis Plc)
- Foamix Pharmaceuticals Ltd.
Key Topics Covered:
1. Executive Summary
3. Global Market Analysis
4. Product Analysis
5. Country/Regional Analysis
6. Competitive Landscape
7. Company Profiling
For more information about this report visit https://www.researchandmarkets.com/research/fkj33l/global_acne